Cis-epoxide compounds of formula (I-1) and pharmaceutically acceptable salts, hydrates and solvates thereof: ##STR1## wherein: R.sup.1 is a cycloalkyl, or aryl-substituted lower alkyl group; A is a functionalized acyl group of the formula ##STR2## wherein R.sup.2 is a C.sub.1-4 alkyl, or amide-substituted C.sub.1-2 alkyl group; R.sup.3 is a C.sub.1-4 alkoxy, aryloxyalkyl or arylalkoxy, or a nitrogen-containing aromatic radical, or a lower alkoxy group substituted with a nitrogen-containing aromatic radical, or a radical having the formula of ##STR3## wherein R.sup.4 is a hydrogen or a methyl group and R.sup.5 is an alkyl group substituted with a nitrogen-containing aromatic radical; and m is 0 or 1; and B is a functionalized amino group of the formula ##STR4## wherein R.sup.8 and R.sup.9 are independently a C.sub.1-4 alkyl group optionally substituted with an aromatic radical, or an aromatic group.
化合物(I-1)的顺式环氧化合物及其药学上可接受的盐、
水合物和溶剂化合物:##STR1## 其中:R.sup.1是环烷基或芳基取代的较低烷基基团;A是式子##STR2##的官能化酰基,其中R.sup.2是C.sub.1-4烷基或酰胺取代的C.sub.1-2烷基基团;R.sup.3是C.sub.1-4烷氧基、芳氧基烷基或芳基烷氧基,或含氮芳基基团,或取代含氮芳基基团的较低烷氧基,或具有式子##STR3##的基团,其中R.sup.4是氢或甲基基团,R.sup.5是取代含氮芳基基团的烷基基团;m为0或1;B是式子##STR4##的官能化
氨基基团,其中R.sup.8和R.sup.9分别是C.sub.1-4烷基基团(可选地取代芳基基团)或芳基基团。